As Plan S Takes Effect, Some Anticipate Inequitable Outcomes
As Plan S Takes Effect, Some Anticipate Inequitable Outcomes
The plan’s signatories seek to make the results of their funded research available to all, but some scientists say the transition to open access has led to climbing publication fees and could exacerbate global disparities.
The plan’s signatories seek to make the results of their funded research available to all, but some scientists say the transition to open access has led to climbing publication fees and could exacerbate global disparities.
cost
Infographic: The Value of Scaling: PSC Suspension Cultures
Thermo Fisher Scientific | Mar 17, 2021 | 1 min read
As research and therapeutic applications for pluripotent stem cells (PSCs) grow, so does the need to reliably and cost-effectively generate large numbers of high-quality cells.
NYU Medical School Is Now Free, Almost
Shawna Williams | Aug 17, 2018 | 1 min read
All students’ tuition will be funded through its endowment.
Stressed Rodents Make Different Choices
Katarina Zimmer | Mar 1, 2018 | 4 min read
Chronic stress tweaks a circuit in the brain that influences how lab rodents make tough decisions.
Opinion: Understanding and Coping With Rising Publication Costs
M. Bishr Omary and Theodore S. Lawrence | Sep 1, 2017 | 6 min read
As article processing charges top $5,000 at some research journals, authors and institutions have means of negotiating better deals or finding less expensive options.
Zika's Economic Burden
Jef Akst | May 11, 2017 | 2 min read
A new analysis estimates that the viral disease could cost between $183 million and more than $10 billion in the U.S. alone.
Another Drug Price Hike
Bob Grant | Mar 28, 2016 | 1 min read
Valeant Pharmaceuticals is criticized for jacking up the price of a drug used in assisted suicide.
Daraprim Discounts Offered
Karen Zusi | Nov 26, 2015 | 1 min read
Turing Pharmaceuticals will soon offer discounts to hospitals for its toxoplasmosis-fighting drug, the company announced, but some say the proposed price reductions are not enough.
Drug Pricing Incites Outrage
Kerry Grens | Sep 22, 2015 | 2 min read
Will public disgust over dramatic hikes in the cost of medications change industry practices?
Science at a Premium
Kerry Grens | Mar 14, 2015 | 3 min read
Although research supplies are exempted from Argentina’s import restrictions, regulations for bringing materials into the country are hampering science nonetheless.